Pharmacogenomic insights into atorvastatin and rosuvastatin adverse effects: a prospective observational study in the UAE’s multiethnic population

This study highlights the importance of genetic testing and demographic factors, such as ethnicity and gender, in tailoring statin therapy to minimize adverse effects. Despite extensive research on PGx-guided statin prescribing, clinical implementation remains limited. Integrating PGx testing into routine practice and enhancing physician awareness of genetic and demographic risk factors can improve the safety, efficacy, and adherence of lipid-lowering therapies in diverse populations.

Authors

Institutions

Publication Details

Journal
Human Genomics
Published
2025-04-25
DOI
https://doi.org/10.1186/s40246-025-00753-6
Citations
4
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
6.02

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacogenomic insights into atorvastatin and rosuvastatin adverse effects: a prospective observational study in the UAE’s multiethnic population

Zeina N. Al-Mahayri, Mais N. Alqasrawi, George P. Patrinos, Sahar M. Altoum et al.
4 citations
Human Genomics
Lipoproteins and Cardiovascular Health
6.02
article

Pharmacogenomic insights into atorvastatin and rosuvastatin adverse effects: a prospective observational study in the UAE’s multiethnic population

Zeina N. Al-Mahayri, Mais N. Alqasrawi, George P. Patrinos, Sahar M. Altoum, Dana Hamza, Juma Alkaabi, Virendra Misra, Salahdein Aburuz, Fatma Al‐Maskari, Bassam R. Ali, Areej S. Albawa’neh, Lubna Q. Khasawneh, Husam Ouda, Lilas Dabaghie
article en
4 citations

Abstract

This study highlights the importance of genetic testing and demographic factors, such as ethnicity and gender, in tailoring statin therapy to minimize adverse effects. Despite extensive research on PGx-guided statin prescribing, clinical implementation remains limited. Integrating PGx testing into routine practice and enhancing physician awareness of genetic and demographic risk factors can improve the safety, efficacy, and adherence of lipid-lowering therapies in diverse populations.

Human GenomicsVol. 19(1)
Abu Dhabi University (AE), University of Patras (GR), United Arab Emirates University (AE), Emirates Foundation (AE), Al Ain Hospital (AE)
Ministry of Higher Education and Scientific Research, Ministry of Education, India, United Arab Emirates University
Openalex Percentile: Top 4%
Lipoproteins and Cardiovascular Health
6.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pharmacogenomic insights into atorvastatin and rosuvastatin adverse effects: a prospective observational study in the UAE’s multiethnic population — Zeina N. Al-Mahayri, Mais N. Alqasrawi, et al. · Human Genomics (2025) | TGRS Research Map | TGRS